Sipuleucel-T cost too high for prostate cancer patients Final draft guidance not recommending sipuleucel-T for use with: Prostate cancer in men whose disease has spread, Who have few symptoms and with disease not yet suitable for chemotherapy treatment. Evidence showed price to NHS too high for potential benefit it may provide to patients. Sipuleucel-T, known…
